Charts

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (OTC: INFIQ) between January 5, 2022 and July 24, 2023, both dates inclusive (the “Class Period”), of the important October 16, 2023 lead plaintiff deadline.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”) (NASDAQ: INFI) in the United States District Court for the District of Massachusetts on behalf of all persons and entities who purchased or otherwise acquired Infinity securities between January 5, 2022 and July 24, 2023, both dates inclusive (the “Class Period”). Investors have until October 16, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

San Diego, CA -- (SBWIRE) -- 10/09/2023 -- The Shareholders Foundation announced that a deadline is coming up on October 16, 2023 in the lawsuit filed for certain investors of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI).

Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares increased by 23.7% to $0.04 during Wednesday's after-market session. Trading ...

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the ...

Gainers Avalo Therapeutics (NASDAQ:AVTX) stock moved upwards by 54.3% to $0.19 during Wednesday's regular session. As of 13:30 EST, ...

Gainers Avalo Therapeutics (NASDAQ:AVTX) shares rose 73.8% to $0.21 during Wednesday's pre-market session. The market value of their ...

LOS ANGELES, CA / ACCESSWIRE / September 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Infinity Pharmaceuticals, Inc. ("Infinity" or "the Company") (NASDAQ:INFI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES / ACCESSWIRE / September 1, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Infinity Pharmaceuticals, Inc. ("Infinity" or "the Company") (NASDAQ:INFI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Gainers Axcella Health (NASDAQ:AXLA) stock rose 14.4% to $0.52 during Tuesday's after-market session. Axcella Health's trading volume ...

San Diego, CA -- (SBWIRE) -- 08/28/2023 -- An investor, who purchased shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), filed a lawsuit over alleged violations of Federal Securities Laws by Infinity Pharmaceuticals, Inc.

Gainers MSP Recovery (NASDAQ:LIFW) stock increased by 14.0% to $0.08 during Friday's after-market session. At the close, MSP Recovery's ...

Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company") (NASDAQ: INFI) and certain of its officers.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”) (NASDAQ: INFI) in the United States District Court for the District of Massachusetts on behalf of all persons and entities who purchased or otherwise acquired Infinity securities between January 5, 2022 and July 24, 2023, both dates inclusive (the “Class Period”). Investors have until October 16, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Infinity Pharmaceuticals, Inc. (INFI) Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. ChatGPT IPO Could Shock the World, Make This Move Before the Announcement It doesn’t matter if you have $500 or $5 million. Do this now. The $1 Investment You MUST Take Advantage of Right Now

Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Infinity Pharmaceuticals, Inc. (INFI) (“Infinity” or the “Company”) (Nasdaq: INFI) securities between January 5, 2022 and July 24, 2023, inclusive (the “Class Period”). Infinity investors have until October 16, 2023 to file a lead plaintiff motion.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) between January 5, 2022 and July 24, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 16, 2023.

Gainers Tivic Health Systems (NASDAQ:TIVC) stock increased by 47.2% to $0.1 during Thursday's pre-market session. The company's market ...

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently ...

Gainers 180 Life Sciences Corp. (NASDAQ: ATNF) shares surged 109.2% to $1.58 in pre-market trading after falling over 6% on ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time to start Wednesday with an overview of all the biggest pre-market stock movers traders need to know about this morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Name for 2023 Could Be About to Ignite This $20.6 Trillion Wealth Shift Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

Gainers Infinity Pharmaceuticals (NASDAQ:INFI) stock moved upwards by 60.9% to $0.14 during Tuesday's regular session. Trading volume ...

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate ...

Gainers Vivos Therapeutics (NASDAQ:VVOS) shares moved upwards by 102.7% to $0.53 during Tuesday's pre-market session. The company's ...

Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Datasea (DTSS) stock is falling on Friday after the company's shares underwent a rally yesterday on a securities purchase agreement. The post Why Is Datasea (DTSS) Stock Down 36% Today? appeared first on InvestorPlace. More From InvestorPlace The #1 AI Name for 2023 Could Be About to Ignite This $20.6 Trillion Wealth Shift Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Proterra (PTRA) stock is plummeting on Tuesday after the electric vehicle (EV) company filed for Chapter 11 bankruptcy protection. The post Why Is Proterra (PTRA) Stock Down 65% Today? appeared first on InvestorPlace. More From InvestorPlace The #1 AI Name for 2023 Could Be About to Ignite This $20.6 Trillion Wealth Shift Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biophytis (BPTS) stock is soaring higher on Tuesday as investors react to a positive opinion for its upcoming Phase 3 clinical trial. The post Why Is Biophytis (BPTS) Stock Up 18% Today? appeared first on InvestorPlace. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Infinity Pharmaceuticals (INFI) stock is rocketing higher on Tuesday morning despite a lack of news from the biopharmaceutical company. The post Why Is Infinity Pharmaceuticals (INFI) Stock Up 84% Today? appeared first on InvestorPlace. More From InvestorPlace The #1 AI Name for 2023 Could Be About to Ignite This $20.6 Trillion Wealth Shift Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Name for 2023 Could Be About to Ignite This $20.6 Trillion Wealth Shift Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

Gainers Vistagen Therapeutics (NASDAQ:VTGN) shares rose 871.4% to $16.32 during Monday's regular session. Trading volume for this ...

Infinity Pharmaceuticals today announced a series of actions designed to reduce burn rate and enhance ability to maximize value of eganelisib

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor ...

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares are trading lower by 40.3% to $0.13 Monday morning after it terminated its ...

Gainers PaxMedica (NASDAQ:PXMD) stock increased by 24.3% to $1.0 during Monday's pre-market session. The market value of their ...

Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, announced that it has terminated its previously announced merger agreement providing for the merger with MEI Pharma, Inc. (“MEI”).

Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) rose 45% to $0.2890 in pre-market trading after falling over 8% on Friday. AMC ...